Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Baxalta
Biotech
Ex-Shire cancer leader raises cash for solid tumor research
Randolf Kerschbaumer, the CEO of OncoOne, is working with other ex-Shire employees to target oxMIF using several different modalities.
Nick Paul Taylor
Mar 18, 2020 6:00am
Gilead’s Kite bags option to buy gamma delta startup Gadeta
Jul 19, 2018 8:30am
Roche gets priority review for hyped hemophilia A prospect
Aug 24, 2017 7:40am
Longevity Fund raises cash to back anti-aging startups
Aug 23, 2017 8:57am
Alexion scraps Moderna pact as new CEO cleans house
Jul 27, 2017 10:10am
Shire gets injunction against hemophilia rival Roche
Jul 10, 2017 7:33am
